Gossamer Bio, Inc. (GOSS)
2.70
-0.17
(-5.92%)
USD |
NASDAQ |
Jan 23, 16:00
2.75
+0.05
(+1.85%)
After-Hours: 20:00
Gossamer Bio Research and Development Expense (TTM): 161.14M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 296.43M |
| XOMA Royalty Corp. | 2.295M |
| Rezolute, Inc. | 61.92M |
| Axsome Therapeutics, Inc. | 188.68M |
| Crinetics Pharmaceuticals, Inc. | 309.89M |